Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Discussion This study showed that a multistrategic, multistakeholder intervention targeting medicine use and biopsychosocial aspects of chronic non-cancer pain including pain neuroscience education, catastrophising and cognitive factors was associated with a reduction in opioid use and increased use of psychology services among patients who were using opioids.
The intervention The intervention comprised the following components for each target group: For doctors: An audit with feedback identifying each of the doctor’s patients who had been taking opioids for at least 3 months and the average oral morphine equivalent (OME) dose of opioid provided to the patient each month over the last 12 months.
To view the full text, please login as a subscribed user or purchase a subscription . Click here to view the full text on ScienceDirect. Most studies assessing the effect of central nervous system (CNS)-acting medicines on cognitive disturbances have focused on the use of individual medicines. The impact on cognitive function when another CNS-acting medicine is added to a patient's treatment regimen is not well known.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
